Sign in

CIK 0001635088

  • Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
Operating
EIN
981173944
Phone
+44 12955950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$63,942,807
in 12 filings, $45.5M under 10b5-1 plans

Net −$63,942,807. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-20 Humes Jennifer Chief Accounting Officer Shares withheld for taxes −3,880 $39.77 $154K 106,419
2026-06-20 Humes Jennifer Chief Accounting Officer Shares withheld for taxes −3,582 $31.43 $113K 109,782
2026-04-20 Humes Jennifer Chief Accounting Officer Grant or award +29,173 113,364
2026-04-20 Humes Jennifer Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +27,157 27,157
2026-04-08 Humes Jennifer Chief Accounting Officer Sale −13,538 $28.37 $384K 84,191
2026-03-20 Humes Jennifer Chief Accounting Officer Shares withheld for taxes −14,526 $27.70 $402K 97,729
2025-03-20 Humes Jennifer Chief Accounting Officer Grant or award +112,255 112,255
2025-03-20 Humes Jennifer Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +115,108 115,108

Page 1 of 1 · 8 trades